Skip to content

FILANA THERAPEUTICS, INC.

FLNA

CIK 0001069530

← back to feed
Revenue (TTM)
$8.6M
+1,700.0% YoY Q1 May 2026
Net Income (TTM)
−$88.77M
−273.7% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.20
−28.8% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-1,081.5%
Q1 May 2026
Net Margin
-1,032.2%
Q1 May 2026
Free Cash Flow (TTM)
−$53.38M
Q1 May 2026
Cash
$86.57M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
48.31M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings